These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10280327)

  • 1. Drug prescribing: a discussion of its variability and (ir)rationality.
    Carrin G
    Health Policy; 1987 Feb; 7(1):73-94. PubMed ID: 10280327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.
    Kravitz RL; Epstein RM; Feldman MD; Franz CE; Azari R; Wilkes MS; Hinton L; Franks P
    JAMA; 2005 Apr; 293(16):1995-2002. PubMed ID: 15855433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
    Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
    CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the appropriateness of physician prescribing.
    Lexchin J
    Int J Health Serv; 1998; 28(2):253-67. PubMed ID: 9595343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing patterns of rural family physicians: a study in Kermanshah Province, Iran.
    Ahmadi F; Zarei E
    BMC Public Health; 2017 Nov; 17(1):908. PubMed ID: 29183293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance for drug prescribing.
    Soumerai SB; McLaughlin TJ; Avorn J
    Qual Assur Health Care; 1990; 2(1):37-58. PubMed ID: 2103870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumers' reports on the health effects of direct-to-consumer drug advertising.
    Weissman JS; Blumenthal D; Silk AJ; Zapert K; Newman M; Leitman R
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-82-95. PubMed ID: 14527237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of educational outreach ('academic detailing') to improve clinical decision making.
    Soumerai SB; Avorn J
    JAMA; 1990 Jan; 263(4):549-56. PubMed ID: 2104640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug product advertising and prescribing: a review of the evidence.
    Smith MC
    Am J Hosp Pharm; 1977 Nov; 34(11):1208-24. PubMed ID: 412419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do we know about direct-to-consumer advertising of prescription drugs?
    Calfee JE
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-116-9. PubMed ID: 14527242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
    Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-consumer marketing of prescription drugs: creating consumer demand.
    Hollon MF
    JAMA; 1999 Jan; 281(4):382-4. PubMed ID: 9929096
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics of primary health care units with focus on drug information from the pharmaceutical industry and adherence to prescribing objectives: a cross-sectional study.
    Carlzon D; Gustafsson L; Eriksson AL; Rignér K; Sundström A; Wallerstedt SM
    BMC Clin Pharmacol; 2010 Feb; 10():4. PubMed ID: 20156362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influences of drug companies' advertising programs on physicians.
    Güldal D; Semin S
    Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elderly patients in general practice: diagnoses, drugs and inappropriate prescriptions. A report from the Møre & Romsdal Prescription Study.
    Straand J; Rokstad KS
    Fam Pract; 1999 Aug; 16(4):380-8. PubMed ID: 10493709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision making and prescribing patterns--a literature review.
    Bradley CP
    Fam Pract; 1991 Sep; 8(3):276-87. PubMed ID: 1959729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do drug company promotions influence physician behavior?
    Goodman B
    West J Med; 2001 Apr; 174(4):232-3. PubMed ID: 11290664
    [No Abstract]   [Full Text] [Related]  

  • 20. Advertising and prescription drugs: promotion, education, and the public's health.
    Avorn J
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-104-8. PubMed ID: 14527239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.